6 Monster Stock Market Predictions for the July 23 Trading Session

6 Monster Stock Market Predictions for the July 23 Trading Session

July 23 – Stock mentions: SPY, BABA, NVDA, FB, INTC, MSFT

Michael Kramer and the clients of Mott Capital own MSFT

US Trading

  • S&P 500 Futures +9 points
  • US 10- Year 2.06%
  • US Dollar 97.48
  • Oil $55.94
  • VIX 13.23

International Trading

  • Shanghai +0.45%
  • HSI +0.34%
  • Nikkei +0.95%
  • KOSPI +0.39%
  • FTSE +0.61%
  • DAX +1.75%

Premium Content: Why Amazon May Drop

Stock Market Predictions for July 23:

S&P 500 (SPY)

S&P 500 is pointing to a higher opening and set up to do battle today with resistance around 3,000 and the downtrend. We should find out relatively early on which way the index is heading. I noted last night that an increase above 3,000 signals a breakout and potential for a further rise. However, should it fail it could signal a steeper drop is on the way.

Alibaba (BABA)

Alibaba’s stock appears to be getting ready to take its next leg higher towards $183.

Facebook (FB)

Facebook is rising and is now attempting to break out at $203. I continue to think FB could head towards $218.

Nvidia (NVDA)

Nvidia looks as if it getting ready to move towards $178.

Microsoft (MSFT)

Microsoft is beginning to look more and more like it is heading for its next leg higher, not lower. A change from my view yesterday, yes, I am aware.

Intel (INTC)

Should Intel rise above $52.50 the stock can work to fill that gap at $57.25

Have a good day.

-Mike

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.